Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$DMTK agree, very much so.
$DMTK yep and by volume most of retail still has no clue.
Agreed this stock reminds me of EXAS , what a great day today....should see 20.00 soon.
DMTK
nice close at HOD; 'I think' she's slowly getting found...
$DMTK imagine the revenue explosion after 2/10/20 when doctors across the USA will order the PLA for their patients instead of more expensive and less accurate skin biopsies when full Medicare coverage begins..flying low is right this stock is the textbook definition of a sleeping giant $$$ their Pigmented Lesion Assay will be the new Standard of Care in early detection of skin cancer like $EXAS Cologuard is to colon cancer..skin cancer is the #1 most common type.
This could be a $30 to $50 stock within a year.
Loved the action today. I was worried about it leaving a gap with yesterday's news AH but it opened up nice so no gap.....I prefer the morning PRs instead. But what a great day. .... next week push should be strong. enjoy the long weekend my friend .
DMTK
I kind of like it flying low, get mostly Tutes and real investors pushing it up. DMTK 2020
DMTK
looking very strong now; just the start imo… g/l!!
$DMTK the monster of 2020 still flying under radar.
LA JOLLA, Calif.--(BUSINESS WIRE)--Jan. 16, 2020-- DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it has contracted with a regional health plan to make DermTech’s gene expression based Pigmented Lesion Assay (“PLA”) for the early detection of melanoma available to the regional health plan’s commercial and Medicare Advantage membership. This is the first contract with this health plan that provides coverage for the PLA.
DermTech’s PLA is the first non-invasive gene expression test for the early detection of melanoma. The PLA has a 99% negative predictive value (“NPV”), meaning there is a less than 1% chance of the PLA missing a melanoma when administered properly.
“We are excited to announce that our test is now available to a segment of commercial and Medicare Advantage members. Our PLA test offers significant benefits in early melanoma detection and reduced biopsies of benign lesions while also reducing costs to the healthcare system,” said Dan Visage, Senior Vice President of Payor Access.
https://investors.dermtech.com/news-releases/news-release-details/dermtech-enters-commercial-and-medicare-advantage-payor-coverage
My guess is that this was just way too frontloaded by social media traders with big followings; while it created that beautiful run into the $15's it just wasn't sustainable with all those sheep.
I personally don't think we have seen much institutional interest up to this point and that it's been mostly retail-
The CMS approval was a given but the pricing announced today was very favorable IMO. I expected us to rally or at a minimum end in the green today. The product 'should be' a game-changer AND the team(money) behind this is about as good as one could wish for IMO.
'If' it's just retail capitulation, we should be close now(?) Those in cheap are jumping out while they still have profits and those in high are bailing to save what's left. For those of us who see the bigger picture and are here for the medium-long term, 'I think' it's just a matter of time. My entire position is in the warrants as I fully expect DMTK to be 'over' $30 by 2024.
Time will tell...
Good Luck!!
Baffling reaction to approval and pricing ?
760.00 per test, big revenues are coming for sure .
DMTK
Great news, even Primary Dr.s can use it before a dermatolgist Dr. Visit. Huge revenues coming.
DMTK
IMO, too many people were in this early for the CMS approval pop; sell the news now in progress
Looks like an Institutional buyer tying to keep in 12.00 range while they load more before running this up over 20.00 soon. We should see the delayed PR this week. GLTA
DMTK
not sure either; I think 'everyone' (including myself) thought the CMS approval was going to gap us up 50%+ and thus far crickets. 'Maybe' it was already priced in as a sure thing(?) 'Maybe' the pr will help(?)
I haven't sold any and am waiting for a big move at some point(??)
g/l!!
This is big news , not sure why the delay on a PR.
DMTK
not the reaction I expected either BUT am also in it for the med-long term
g/l!!
$DMTK guess I’m marginally surprised they haven’t PR’d this yet. No matter great news for the long holder like myself. GLTA!
fingers crossed! getting antsy here LOL
Thanks db7, AH ;]
DMTK
Hi greens, I do not know the exact time it is published BUT I did some research into EXAS and it's CMS LCD approval and judging by the trading action it appears the approval was posted after hours(?)
Look at what EXAS did on it's CMS LCD Approval:
10/09/2014 closed at $18.12 on 980,892 shares traded
* CMS LCD approval on 10/9 *
10/10/2014 gapped up and hit a high of $26.79 on 17,259,562 shares traded
Good morning db7, looks like news comes next thurs. unless CMS releases news sometime later today ?
DMTK
It's so thin I think the moves will be dramatic up and down; 'I think' we will get at least a 50% move up on the day of the CMS LCD approval (assuming we do get approval)… !ONLY 'MY' OPINION! EXAS moved about 50% when it got it's LCD approval and we are much thinner..etc...etc..
Thanks for the info....do you think there will be any shorts trying to manipulate this low float ?....The way i see it is if they did they would be completely ignoring the awesome fundamentals and earnings potential in the near future .
DMTK
Hi greens, i mentioned cms lcd approvals seem to all get published on Thursday's. Not sure if this Thur or the next or a Thur month(s) from now. I haven't sold any warrants, actually added a tiny bit more
G/L!!
hello db7, do you still expect news on Thursday ? Added more shares and warrants today on the dip. With 300.00 savings cost Vs. Biopsy this dmtk skin Patch will become a SOC with Medicare and expect huge revenues.
DMTK
she is just so thin; I think we're going to do very well with DMTK and DMTKW as long as we get that approval
This is truly looking like it could see $25+ on approval imo
BUT as I mentioned before what i'm really hoping for is an insane, parabolic move... aka to like $40+
time will tell....
g/l!!
Agreed. 'Hoping' it goes on a crazy, low-float multi-day run. Not sure if you saw it and it's definitely not apples to apples but a few weeks back krtx went from like $18 to $150. An epic run like that here would be much appreciated lol
$DMTK Medicare approval = $20.00 plus IMHO.
Great day db7, I think now that it is over 10.00 it will move faster. CMS news ...tick tock
DMTK
beautiful day, sooo thin!
Warrants haven't even begun imho. I'm hoping for $2+ out of them. Time will tell-
Thanks for sharing that Tall! $15 seems extremely conservative imo. Could hit that in a few days of volume w/o news IMO
Hoping for $20+ day of or after Medicare approval (assuming it's granted etc)
G/L!!
The float is getting locked up, not much left for retail......I was watching the warrants sky rocket today congrats to you. Medicare news will be explosive as more people find out about the revenues coming .
DMTK
Lake Street Capital Markets Analyst Thomas Flaten initiated coverage of DermTech, Inc. with a BUY rating and price target of $15 (DMTK $7.60).
DermTech is a molecular diagnostics company developing and marketing novel gene expression-based tests for various dermatologic applications, including the Pigmented Lesion Assay for the diagnosis of melanoma. Combining gene expression assays with the Company’s adhesive patch technology allows for non-invasive testing. In addition to advancing a proprietary pipeline of diagnostic tests, the Company also partners with pharmaceutical companies for the use of its core technology in clinical studies.
hi greens! Agreed, was just telling my buddy I am anxious for the medicare approval as I can't even imagine what this will do if/when it gets a million+ in volume.
Nice volume today db7, Looking like this might be the start of an Epic Run up with big news expected soon. Sky is the limit.
DMTK
thanks for sharing that greens; exciting potential!
Yep, see the DMTKW board. G/L!
I spoke with IR today.
The DMTKW warrants expire in 2024.
4 warrants and $23 will get you one share of DMTK.
DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that company management is scheduled to participate at the following upcoming investor conferences:
John Dobak, M.D., Chief Executive Officer, will be presenting at the Stifel 2019 Healthcare Conference on Wednesday, November 20, 2019 at 8 a.m. Eastern Time at the Lotte New Palace Hotel in New York.
John Dobak, M.D., Chief Executive Officer, will be presenting at the Canaccord Genuity’s 13th Annual Medical Technologies & Diagnostics Forum on Thursday, November 21, 2019 at 1:30 p.m. Eastern Time at the Westin Grand Central in New York.
Good link, I bought more shares this week. When volume picks up on this low floater the stock will fly.
DMTK
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
111
|
Created
|
09/11/19
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |